Tardyliq

Medicinal product

(Invented) name

Tardyliq

Active substance (s)

Geležies (II) sulfatas heptahidratas

Strength

20 mg/ml

Pharmaceutical form

geriamasis tirpalas

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B03AA07, Ferrous sulfate

Marketing authorisation holder

Pierre Fabre Medicament, Prancūzija

Date of authorisation

2023-08-03

Date of renewal

Documents

5224 Pakuotės lapelis 2024 12 13.docx

5224 Tardyliq PCS PL 2024 12 13.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

FR/H/0778/002/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

1 ml tirpalo yra:	1 ml
Geležies (II) sulfatas heptahidratas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111441	97554	1097554	buteliukas	90 ml N1 (su 5 ml pipete)		Receptinis	LT/1/23/5224/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-08-03	Registruotas